AML patients overestimate treatment risk and chance of cureOctober 25, 2017AMLPatient & Survivor Care
Anidulafungin effectively treated invasive pediatric candidiasis in open-label trialOctober 5, 2017PediatricsPatient & Survivor CareCellular Therapy
ASCO issues guideline on communication with patientsSeptember 11, 2017Patient & Survivor CareBusiness of Medicine
Is pain or dependency driving elevated opioid use among long-term cancer survivors?September 6, 2017Patient & Survivor CareHodgkin Lymphoma
Pembrolizumab, nivolumab linked to 3% rate of neurologic eventsSeptember 5, 2017Patient & Survivor CareHodgkin Lymphoma
Off-the-shelf T cells used to treat viral infections after HSCTAugust 16, 2017Cellular TherapyPatient & Survivor Care
ALLOZITHRO trial: HSCT patients fared worse with azithromycinAugust 8, 2017Cellular TherapyPatient & Survivor Care
Solid organ transplantation contributes significantly to incidence of NHL among children and adolescentsAugust 3, 2017PediatricsPatient & Survivor CareTransplantAggressive Lymphomas
Alopecia may be permanent in one in four pediatric HSCT patientsAugust 2, 2017PediatricsPatient & Survivor CareCellular Therapy
Ibrutinib becomes first FDA-approved treatment for chronic GVHDAugust 2, 2017Cellular TherapyPatient & Survivor Care
Idarucizumab reversed dabigatran completely and rapidly in studyJuly 11, 2017ThrombosisPatient & Survivor Care
Tool indicates fracture risk after HSCTJuly 10, 2017Multiple MyelomaPatient & Survivor CareCellular Therapy
